Advertisement
U.S. Markets closed

Boundless Bio, Inc. (BOLD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W
3.0500+0.0200 (+0.66%)
At close: 04:00PM EDT
3.0500 0.00 (0.00%)
After hours: 04:02PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
Operating Expense
65,023
54,796
46,469
25,301
Operating Income
-65,023
-54,796
-46,469
-25,301
Net Non Operating Interest Income Expense
7,171
5,282
668
96
Other Income Expense
129
80
-100
-5
Pretax Income
-57,723
-49,434
-45,901
-25,210
Net Income Common Stockholders
-57,723
-49,434
-45,901
-25,210
Diluted NI Available to Com Stockholders
-57,723
-49,434
-45,901
-25,210
Basic EPS
-3.53
-3.53
-3.28
-1.80
Diluted EPS
-3.53
-3.53
-3.28
-1.80
Basic Average Shares
13,990
13,990
13,990
13,990
Diluted Average Shares
13,990
13,990
13,990
13,990
Total Operating Income as Reported
-65,023
-54,796
-46,469
-25,301
Total Expenses
65,023
54,796
46,469
25,301
Net Income from Continuing & Discontinued Operation
-57,723
-49,434
-45,901
-25,210
Normalized Income
-57,723
-49,434
-45,901
-25,210
Interest Income
7,171
5,282
668
96
Net Interest Income
7,171
5,282
668
96
EBIT
-65,023
-54,796
-46,469
-25,301
EBITDA
-64,013
-53,839
-45,527
-24,619
Reconciled Depreciation
1,010
957
942
682
Net Income from Continuing Operation Net Minority Interest
-57,723
-49,434
-45,901
-25,210
Normalized EBITDA
-64,013
-53,839
-45,527
-24,619
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0